Biobanking: Technologies and Global Markets

Report Code: BIO084C

Publish Date: Feb 2022

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for biobanking is estimated to increase from $61.1 billion in 2021 to $76.2 billion by 2026, at a compound annual growth rate (CAGR) of 4.5% during 2021-2026.

Report Includes

  • 22 data tables and 29 additional tables
  • An up-to-date review and analysis of the global markets for biobanking technologies
  • Analyses of the global market trends, with data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Highlights of the upcoming market potential for biobanking technologies, and areas of focus to forecast this market into various segments and sub-segments
  • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors that will drive future demand for biobanking products
  • Evaluation and forecast the overall market size for biobanks, forecasted growth trends, and corresponding market share analysis by sample type, application, ownership type, and region
  • Identification of novel biobanking products and promising new technologies still in the development and testing stage and assess the probability that they will be commercialized successfully in the next five years
  • Review of emerging companies and the leading competitors in the prevailing biobanking industry
  • Insight into recent patent activities on biobanking techniques, R&D activities, clinical trials under process, and selected list of biobanking studies
  • Descriptive company profiles of the major global players, including Agilent Technologies Inc., AstraZeneca plc, Bruker Corp., Hamilton Co., Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.

Report Scope

This report aims to provide a comprehensive study of the global market for biobanking. It provides a detailed description of the different types of biobanks (disease-oriented/clinical based and population-based) worldwide. The biobanking market is segmented based on their application as basic/scientific research and clinical research/therapeutics. Each application segments’ historical and projected market revenues are provided in the report. The global market for biobanking is also segmented based on sample type (as biofluids, tissue, stem cells, DNA/RNA and others) and ownership types (government agencies/public sector providers, academic institutes/universities, non-profit organizations and private organizations). The market revenue for each geographical segment, including North America, Europe, Asia-Pacific and Rest of the World (ROW), have also been provided in the report.

For an in-depth understanding of the market, profiles of market participants are also part of this report. This report also discusses driving and restraining factors and key trends in the biobanking market.

This research covers biobanks dealing with basic science and clinical research. Forensic science, paternity testing, cryopreservation facilities or screening disease testing for newborns and fertility clinics dealing with ovum, sperm and embryo biobanks are not covered in this report. Transplantation and graft-related biobanks dealing with heart valves, cornea and cartilage/tendon are also not covered. Tissue banks for orthopedic, spine, dental, maxillofacial surgery and stem cells biobank for regenerative medicine are also not covered in this report.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $58.5 billion
Market size forecast $76.1 billion
Growth rate CAGR of 4.5% from 2021 to 2026
Units considered $ Millions
Segments covered Sample Type, Application, Ownership Type
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Canada, Germany, France, U.K., Italy, Sweden, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Russia, Japan, China, Australia, South Korea, India, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa
Key Market Drivers
  • Increasing Public Funding in Biobank Projects
  • Increasing Applications in Drug Discovery and Development
  • Increasing Pharmaceutical and Biotech R&D Spending
  • Developments in Analytical Technologies and Assay Methods
  • Growing Focus on Mainstream Precision Medicine and Rise of Genomic Medicine/Clinical Genomics
  • Biobanking Technique Advancements
  • Growing Private Biobanking
Companies studied
AGILENT TECHNOLOGIES INC.AMGEN INC.
ASTRAZENECAAVANTOR INC.
AZENTA US INC.BIOKRYO GMBH
BRUKERCENTOGENE N.V.
HAMILTON CO.INDIVUMED GMBH
MERCK KGAAQIAGEN
TECAN TRADING AGTHERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biobanking: Technologies and Global Markets138Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market and Technology Background12Free
Chapter- 4: Current Biobanks Worldwide19Free
Chapter- 5: Analysis of Market Opportunities13Free
Chapter- 6: Market Breakdown by Sample Type6Free
Chapter- 7: Market Breakdown by Application11Free
Chapter- 8: Market Breakdown by Region24Free
Chapter- 9: Market Breakdown by Ownership Type7Free
Chapter- 10: Patent Review/New Developments10Free
Chapter- 11: Company Profiles24Free
Chapter- 12: Appendix: Acronyms2Free
Published - Nov-2016| Analyst - Jackson Highsmith| Code - BIO084B

Report Highlights

The global market for biobanking technologies was valued at $186.3 billion in 2015. This market is expected to increase from $198.2 billion in 2016 to $240.2 billion in 2021 at a compound annual growth rate (CAGR) of 3.9% for 2016-2021.

Report Includes

  • An overview of the global markets for biobanking, the storage of biological samples for the future.
  • Analyses of global market trends, with data from 2015, estimates for 2016 and projections of compound annual growth rates (CAGRs) through 2021.
  • Detailed analyses of how biobanks can lead to new products for specific diseases to overall industry trends.
  • Breakdowns of the biobanking market by product, disease category, and geographic region or country.
  • New products approved by the FDA, and those products expected to be approved within the forecast period.
  • Analysis of the leading competitors, as well as emerging companies in the current worldwide biobanking market.
  • Profiles of the manufacturers of leading products, and their specific product strategies are outlined.
Published - Jun-2011| Analyst - Jackson Highsmith| Code - BIO084A

Report Highlights

The global biobanking market was $141 billion in 2010 and is projected to increase by 30% between 2010 and 2015, at a compound annual growth rate (CAGR) of 5.4%.

Related Reports

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

Metabolomics: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Sep 2023 | Publisher - Bejini Sandeep Kumar | Code - HLC029F

The global market for diabetes therapeutics and diagnostics is estimated to increase from $102.2 billion in 2023 to reach $132.0 billion by 2028, at a compound annual growth rate (CAGR) of 5.2% from 2023 through 2028.

Recent Reports

Commercial Amino Acids

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO007N

The global market for commercial amino acids was valued at $30.1 billion in 2023. It is expected to grow from $31.8 billion in 2024 to $42.8 billion by 2029, at a compound annual growth rate (CAGR) of 6.1% from 2024 through 2029.

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

RNA Sequencing: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO147B

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

European Life Science Tools and Reagents Market

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO262A

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.

Top Trending Reports

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Biobanking: Technologies and Global Markets
Customize Report